EUVIMEDSkopri EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

The WISH 2.0 Intervention for Irritable Bowel Syndrome: Protocol for a Pilot Randomized Controlled Trial

Elizabeth N Madva iD, Jeff C Huffman iD, Helen Burton-Murray iD, Emmett McGranaghan iD, Megan Bidgood iD, Jenny Y Gan iD, Benjamin Wasserman iD, Emily H Feig iD, Brian Healy iD, Kyle Staller iD, Bonney Reed iD, Roberta Sclocco iD and 5 more

JMIR Research Protocols · 2026-07-23 · 15 · e98352-e98352

DOI: 10.2196/98352 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2026-07-23. Written by Elizabeth N Madva and 16 co-authors. Institution: Harvard Medical School, Mass General Brigham, 55 Fruit Street, Boston, MA, 02114, United States, 1-617-726-2000. Major MEDLINE topics: Behavior Therapy, Irritable Bowel Syndrome, Psychology, Positive. 104 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NCATS NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

There is a critical need for acceptable, scalable, and mechanistically targeted behavioral health interventions for irritable bowel syndrome (IBS), known as brain-gut behavior therapies (BGBTs). Although positive psychology (PP) interventions, which focus on the cultivation of positive psychological well-being, have been linked to improved health outcomes across diverse medical populations, they have not yet been investigated in IBS. To address this gap, we developed WISH (Well-Being in IBS: Strengths and Happiness), a novel, 9-week, phone-delivered PP-based BGBT for individuals with IBS.

Objective

This randomized controlled trial (RCT) aims to evaluate the feasibility, acceptability, preliminary effects, and candidate gut-brain mechanisms of a 9-week phone-delivered PP intervention for IBS compared with a time- and attention-matched educational control.

Methods

The WISH 2.0 trial is a parallel-group, 9-week pilot RCT that aims to enroll 50 adults meeting Rome IV criteria for IBS. Participants are randomized (1:1), stratified by IBS subtype and gender, to either the WISH 2.0 intervention or an educational control condition. Both conditions consist of 9 weekly 30-minute phone sessions accompanied by weekly manualized exercises. Primary outcomes are feasibility (proportion completing ≥6 of 9 sessions) and acceptability (weekly ease and utility ratings). Secondary outcomes include WISH 2.0’s preliminary effects on health-related, health behavior, and psychological outcomes, assessed at 4 time points: baseline, intervention midpoint, the postintervention assessment, and the 3-month postintervention assessment. Candidate gut-brain mechanisms that might underlie WISH 2.0’s effects, including changes in autonomic function (heart rate variability), interoception (self-report measure), gene expression (whole transcriptome RNA sequencing), and immune system activity (serum inflammatory biomarkers), will be explored before and after the intervention.

Results

The trial was approved by the Mass General Brigham Institutional Review Board and prospectively registered at ClinicalTrials.gov in March 2025. Funding was awarded in June 2025. Following a study start-up period, recruitment commenced in October 2025 and is ongoing. As of July 2026, 20 participants have been enrolled. Study completion is anticipated in August 2028.

Conclusions

This trial will determine the feasibility and acceptability of WISH 2.0, a novel PP intervention for IBS. Comparative results between WISH 2.0 and an educational control, including the possibility of equivalent outcomes, will provide important mechanistic insights and facilitate further optimization of BGBTs for IBS, informing a future fully powered efficacy trial.

Subjects

MeSH terms (MEDLINE)

Behavior TherapyIrritable Bowel SyndromePsychology, PositiveAdultFemaleHumansMaleMiddle AgedPilot Projects

Author keywords

disorders of gut-brain interactionfunctional gastrointestinal disordersirritable bowel syndromepositive psychologypsychological resilience

Authors and institutions

  • Harvard Medical School, Mass General Brigham, 55 Fruit Street, Boston, MA, 02114, United States, 1-617-726-2000.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
  • Division of Behavioral & Mental Health, Emory + Children's Pediatric Institute, Atlanta, GA, United States.
  • Department of Physical Medicine & Rehabilitation, Harvard Medical School, Spaulding Rehabilitation Hospital, Boston, MA, United States.
  • Department of Pathology, Harvard Medical School, Mass General Brigham, Boston, MA, United States.
  • Division of Digestive and Liver Diseases, Columbia University, NewYork-Presbyterian Hospital, New York, NY, United States.

ORCID profiles: Elizabeth N Madva, Jeff C Huffman, Helen Burton-Murray, Emmett McGranaghan, Megan Bidgood, Jenny Y Gan, Benjamin Wasserman, Emily H Feig, Brian Healy, Kyle Staller, Bonney Reed, Roberta Sclocco, Sami S Amr, Stephen Bartels, Braden Kuo, Laurie Keefer, Christopher M Celano

Funding

  • NIDDK NIH HHS
  • NCATS NIH HHS

Cite

APA

Madva, E. N., Huffman, J. C., Burton-Murray, H., McGranaghan, E., Bidgood, M., Gan, J. Y., Wasserman, B., Feig, E. H., Healy, B., Staller, K., Reed, B., Sclocco, R., Amr, S. S., Bartels, S., Kuo, B., Keefer, L., & Celano, C. M. (2026). The WISH 2.0 Intervention for Irritable Bowel Syndrome: Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols, 15, e98352-e98352. https://doi.org/10.2196/98352

Vancouver

Madva EN, Huffman JC, Burton-Murray H, McGranaghan E, Bidgood M, Gan JY, et al. The WISH 2.0 Intervention for Irritable Bowel Syndrome: Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e98352-e98352. doi:10.2196/98352

BibTeX
@article{Madva2026,
  author = {Madva, Elizabeth N and Huffman, Jeff C and Burton-Murray, Helen and McGranaghan, Emmett and Bidgood, Megan and Gan, Jenny Y and Wasserman, Benjamin and Feig, Emily H and Healy, Brian and Staller, Kyle and Reed, Bonney and Sclocco, Roberta and Amr, Sami S and Bartels, Stephen and Kuo, Braden and Keefer, Laurie and Celano, Christopher M},
  title = {The WISH 2.0 Intervention for Irritable Bowel Syndrome: Protocol for a Pilot Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e98352--e98352},
  doi = {10.2196/98352}
}
Start for free →